484 related articles for article (PubMed ID: 1370077)
1. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment.
Dewar KM; Grondin L; Carli M; Lima L; Reader TA
J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077
[TBL] [Abstract][Full Text] [Related]
2. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
Dewar KM; Reader TA; Grondin L; Descarries L
Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
[TBL] [Abstract][Full Text] [Related]
3. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
Datla KP; Curzon G
Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
[TBL] [Abstract][Full Text] [Related]
4. Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.
Molina-Holgado F; Molina-Holgado E; Leret ML; González MI; Reader TA
Neurochem Res; 1993 Nov; 18(11):1183-91. PubMed ID: 7504790
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]paroxetine binding in rat brain.
Marcusson JO; Bergström M; Eriksson K; Ross SB
J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
7. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei.
Barden N; Daigle M; Picard V; Di Paolo T
J Neurochem; 1983 Sep; 41(3):834-40. PubMed ID: 6192216
[TBL] [Abstract][Full Text] [Related]
8. Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain.
Berger UV; Grzanna R; Molliver ME
Exp Neurol; 1989 Feb; 103(2):111-5. PubMed ID: 2521470
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
Curzon G; Fernando JC; Marsden CA
Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
[TBL] [Abstract][Full Text] [Related]
10. The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat.
Przegaliński E; Jaworska L; Gołembiowska K
Neuropeptides; 1992 Sep; 23(1):19-25. PubMed ID: 1383865
[TBL] [Abstract][Full Text] [Related]
11. Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain.
Zetterström TS; Pei Q; Madhav TR; Coppell AL; Lewis L; Grahame-Smith DG
Neuropharmacology; 1999 Jul; 38(7):1063-73. PubMed ID: 10428425
[TBL] [Abstract][Full Text] [Related]
12. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
De Souza EB; Kuyatt BL
Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of p-chlorophenylalanine on indoleamines in brainstem nuclei and spinal cord of rats. I. Biochemical and behavioral analysis.
Steinman JL; Carlton SM; Haber B; Willis WD
Brain Res; 1987 Nov; 426(2):297-309. PubMed ID: 2446710
[TBL] [Abstract][Full Text] [Related]
14. Effects of idebenone (CV-2619) on metabolism of monoamines, especially serotonin, in the brain of normal rats and rats with cerebral ischemia.
Narumi S; Nagai Y; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y
Jpn J Pharmacol; 1985 Mar; 37(3):235-44. PubMed ID: 2582171
[TBL] [Abstract][Full Text] [Related]
15. Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo.
O'Connell MT; Portas CM; Sarna GS; Curzon G
Br J Pharmacol; 1991 Apr; 102(4):831-6. PubMed ID: 1713108
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic involvement in the cardiovascular stimulation by thyrotropin-releasing hormone (TRH) in anesthetized rats.
Nurminen ML; Paakkari I; Seppälä T
Neurosci Lett; 1991 Jun; 127(2):147-9. PubMed ID: 1715540
[TBL] [Abstract][Full Text] [Related]
17. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product.
Rattray M; Baldessari S; Gobbi M; Mennini T; Samanin R; Bendotti C
J Neurochem; 1996 Aug; 67(2):463-72. PubMed ID: 8764569
[TBL] [Abstract][Full Text] [Related]
18. Effect of p-chlorophenylalanine on cerebral serotonin binding, serotonin concentration and motor activity in the rat.
Steigrad P; Tobler I; Waser PG; Borbély AA
Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):143-8. PubMed ID: 153478
[TBL] [Abstract][Full Text] [Related]
19. Effects of idebenone on metabolism of monoamines and cyclic AMP formation in rats.
Nagai Y; Narumi S; Kakihana M; Yamazaki N; Nagaoka A; Nagawa Y
Arch Gerontol Geriatr; 1989 May; 8(3):273-89. PubMed ID: 2475075
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
